← Open Payments lookup

RENE ALAMO: Open Payments

NPI 1558083402 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$643 in 36 payments from 13 companies in 2025. Trend: 2023 $67 · 2024 $519 · 2025 $643

Food & beverage: $643
CompanyPaymentsAmount
ABBVIE INC.14$154
Lilly USA, LLC2$124
Vanda Pharmaceuticals Inc.4$73
Otsuka America Pharmaceutical, Inc.4$73
Alkermes, Inc.3$54
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$41
Axsome Therapeutics, Inc.1$27
Neurocrine BioSciences, Inc.1$19
Exact Sciences Corporation1$17
Dexcom, Inc.1$17

Products named: ZEPBOUND, VRAYLAR, FANAPT, QULIPTA, REXULTI, CAPLYTA, LYBALVI, Auvelity.

Industry payments across ID — which companies pay providers there.